Added to YB: 2026-08-14
Pitch date: 2026-08-11
EVH [neutral]
Evolent Health, Inc.
+13.66%
current return
Author Info
Jaime Bermejo shares investing thoughts and ideas in his newsletter. Sign up for his newsletter.
Company Info
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
Market Cap
$471.5M
Pitch Price
$4.10
Price Target
8.20 (+76%)
Dividend
N/A
EV/EBITDA
20.44
P/E
-0.92
EV/Sales
0.63
Sector
Health Care Technology
Category
turnaround
What I'm looking at. Returns YTD - Evolent Health, Inc.
EVH (watchlist): Value-based specialty care mgr (oncology/cardiology). Thesis = MER walk-down to 93% (95.3% Q2, guide Q4 -250bps) & EBITDA margin recovery from 4.3% to 8%+ (2023 level). Risk: takes drug cost risk w/o owning pharmacy. 6.3x net debt ($808M/$127M EBITDA), thin FCF. Double if normalizes/refi 2029s; breaks if oncology costs spike.
Read full article (1 min)